• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Hypnodorm
    / Teva


    Active Ingredient

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Tablets

    10 X 2 mg

    not in the basket chart 1000 8097

    Related information


    Dosage

    Treatment should be as short as possible and should be started with the lowest
    recommended dose. The maximum dose should not be exceeded. Generally the duration of treatment varies from a few days to two weeks with a maximum of four weeks, including the tapering off process. Patients who have taken benzodiazepines for a prolonged time may require a longer period during which doses are reduced. Specialist help may be appropriate. Little is known regarding the efficacy or safety of benzodiazepines in long-term use.
    In certain cases, extension beyond the maximum treatment period may be necessary; if so, it should not take place without re-evaluation of the patient’s status. Long-term chronic use is not recommended.
    The product should be taken just before going to bed.
    The dosage should be carefully adapted to the age and the general condition of the patient and to the nosological classification of the sleep disturbance.
    Adults: Half a tablet at bedtime. In severe insomnia, 1 tablet at bedtime.
    Elderly Patients: One quarter of a tablet at bedtime. In severe insomnia, half a tablet at bedtime.


    Indications

    Insomnia of various etiology.


    Contra-Indications

    Known hypersensitivity to benzodiazepines, acute pulmonary insufficiency, respiratory depression, 1st and 3rd trimester pregnancy, acute narrow-angle glaucoma, myasthenia gravis.
    See prescribing information for full details.


    Special Precautions

    Patients with a history of drug abuse or dependence. Prolonged use may cause dependence. Dosage should be decreased gradually, paradoxical reactions have been reported, pregnancy and lactation. In elderly or debilitated patients and in children, the initial dose should be low, increasing gradually. Patients in whom a drop in blood pressure might lead to cardiac complications, impaired renal or hepatic function, chronic pulmonary insufficiency, myasthenia gravis. Ability to perform potentially-hazardous tasks may be impaired.
    See prescribing information for full details.


    Side Effects

    Drowsiness, fatigue and ataxia, especially in elderly or debilitated patients, constipation, diarrhea, dry mouth, nausea, vomiting, increased salivation, incontinence, dysuria, enuresis, changes in libido, urinary retention, menstrual irregularities, bradycardia, tachycardia, hypertension, hypotension, palpitations, visual disturbances, diplopia, urticaria, pruritus, skin rash, dermatitis, hepatic dysfunction, blood dyscrasias.
    See prescribing information for full details.


    Drug interactions

    See prescribing information for full details.


    Manufacturer
    Teva Pharmaceutical Industries Ltd, Israel
    CLOSE